Skip to main content
|

Radiation Therapy for High-Risk Asymptomatic Bone Metastases

Short Title: NRG-CC014


Enrollment Status: Recruiting

NCT #: NCT06745024

Specialty Area: Oncology

Condition Studied: Bone Metastases

Age Groups: Adult; Older Adult

Phase: III


Study Information

Summary / Purpose

To find out if adding radiation therapy to usual care helps prevent bone-related complications—such as fractures, spinal cord compression, or pain—in people with asymptomatic high-risk bone metastases.

Study Type: Interventional
Accepts Healthy Volunteers: No

Who Can Participate

Eligibility Criteria:
  • Adults 18+ years of age
  • Diagnosed with cancer that has spread to the bones
  • Bone metastases are not currently causing symptoms
  • Bone metastases are considered high-risk due to location (e.g., hip, shoulder, long bones, spine) and size (2 cm or larger)

What's Involved

Participation in the study will include:
  • Either radiation therapy or usual care (which may include bone-strengthening medications or observation)
  • Radiation may be delivered in one session or spread over up to five days
  • Blood and tissue sample collection
  • Questionnaires

Principal Investigator

Additional Information

Location: Renown Health, Office of Clinical Research
Address:

1500 E 2nd St. Reno, NV 89502

General Research: 775-982-3646
Oncology Research: 775-982-5050
Email: Renown-CRD@renown.org

Disclaimer: This listing gives you general information about the study and isn't part of the official consent process. If you decide to learn more, the research team will talk with you and check if you meet any additional requirements to join the study.

ER Wait Times

How are wait times calculated?

Our estimated ER wait times reflect the average time from check-in to being seen by a medical professional during triage, where patients are prioritized based on the severity of their condition.

Health & Wellness eNews
Sign Up